Carregant...
The Epothilones: New Therapeutic Agents for Castration-Resistant Prostate Cancer
The management of castration-resistant prostate cancer (CRPC) presents a clinical challenge because of limitations in efficacy and durability with currently available therapeutics. The epothilones represent a novel class of anticancer therapy that stabilizes microtubules, causing cell death and tumo...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AlphaMed Press
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228074/ https://ncbi.nlm.nih.gov/pubmed/21964003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|